United States · FDA National Drug Code directory
Fexofenadine hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 30142-878_849db024-444d-2f42-de16-c0bebb7f0ffb
- Product NDC
- 30142-878
- Form
- TABLET
- Composition / generic term
- Fexofenadine hydrochloride
- Labeler
- KROGER COMPANY
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180930
- Source listing expiry
- 20261231
Source-listed ingredients
- FEXOFENADINE HYDROCHLORIDE — 180 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 BLISTER PACK in 1 CARTON (30142-878-15) / 5 TABLET in 1 BLISTER PACK · 30142-878-15
- 1 BOTTLE in 1 CARTON (30142-878-30) / 30 TABLET in 1 BOTTLE · 30142-878-30
- 2 BOTTLE in 1 CARTON (30142-878-64) / 70 TABLET in 1 BOTTLE · 30142-878-64
- 1 BOTTLE in 1 CARTON (30142-878-70) / 70 TABLET in 1 BOTTLE · 30142-878-70
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →